Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gabriela Alvarado-Luna"'
Autor:
Ricardo Fernández-Ferreira, Pamela Denisse Soberanis-piña, Emilio Conde-Flores, Andrés Mauricio Arroyave-Ramírez, Ileana Mackinney-Novelo, Daniel Motola-Kuba, Jose Manuel Ruiz-Morales, Gabriela Alvarado-Luna, Fredy Chable-Montero
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1860-1867 (2021)
Soft tissue sarcomas represent
Externí odkaz:
https://doaj.org/article/ccdbcad6b0434066b0a756bf891325a6
Autor:
Ricardo Fernández-Ferreira, Andrés Arroyave-Ramírez, Daniel Motola-Kuba, Gabriela Alvarado-Luna, Ileana Mackinney-Novelo, Román Segura-Rivera
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 123-133 (2021)
Phyllodes tumor of the breast is an infrequently encountered fibroepithelial neoplasm, which accounts for 0.3–1% of all tumors. Few case reports have described the occurrence of giant phyllodes tumor. To our knowledge, about 20% of phyllodes tumors
Externí odkaz:
https://doaj.org/article/c304185169e34e57b8513d7a38e9a106
Autor:
Ricardo Fernández-Ferreira, Gabriela Alvarado-Luna, Daniel Motola-Kuba, Ileana Mackinney-Novelo, Eduardo Emir Cervera-Ceballos, Román Segura-Rivera
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1463-1473 (2020)
Eccrine porocarcinoma (EPC) is an infrequent cutaneous neoplasm, and was described in 1963 by Pinkus and Mehregan. It is a rare type of skin tumor (0.005–0.01% of all skin tumors). Less than 300 cases have been described in the entire world medical
Externí odkaz:
https://doaj.org/article/ccae2b01a001409fb30b7455ae64b4f2
Autor:
Ricardo Fernandez-Ferreira, Rita Dorantes-Heredia, Daniel Motola-Kuba, Jose-Manuel Ruiz-Morales, Gabriela Alvarado-Luna, Ileana Mac Kinney-Novelo, Wendy-Rossemary Munoz-Montano, Kevin-Joseph Fuentes-Calvo
Publikováno v:
World Journal of Oncology
Background There are different clinicopathological characteristics that are associated with the prognosis in patients with breast cancer. To date, the prognostic valor of for epithelial cadherin (E cadherin) expression in invasive lobular breast canc
Autor:
Daniel Motola-Kuba, Gabriela Alvarado-Luna, Román Segura-Rivera, Andrés Mauricio Arroyave-Ramírez, Ricardo Fernández-Ferreira, Ileana Mackinney-Novelo
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 1, Pp 123-133 (2021)
Case Reports in Oncology, Vol 14, Iss 1, Pp 123-133 (2021)
Phyllodes tumor of the breast is an infrequently encountered fibroepithelial neoplasm, which accounts for 0.3–1% of all tumors. Few case reports have described the occurrence of giant phyllodes tumor. To our knowledge, about 20% of phyllodes tumors
Autor:
M. Schuler, J.C.-H. Yang, K. Park, J.-H. Kim, J. Bennouna, Y.-M. Chen, C. Chouaid, F. De Marinis, J.-F. Feng, F. Grossi, D.-W. Kim, X. Liu, S. Lu, J. Strausz, Y. Vinnyk, R. Wiewrodt, C. Zhou, B. Wang, V.K. Chand, D. Planchard, SaiHong Ignatius Ou, David Planchard, Keunchil Park, Martin Schuler, James Yang, Vikram Chand, Klaus Rohr, Claudia Bagnes, Claudio Marcelo Martin, Gonzalo Recondo, Juan Jose Zarba, Cesar Blajman, Martín Richardet, Sue-Anne McLachlan, Phillip Parente, Craig Underhill, Catherine Crombie, Paul Mainwaring, Richard Greil, Yves Humblet, Frédérique Bustin, Luciano Carestia, Danny Galdermans, Marc Lambrechts, Laetitia Delval, Piet Vercauter, Caicun Zhou, Jin Wang, Cheng Huang, Xiaoyan Lin, Yilong Wu, Xiaoqing Liu, Ying Cheng, Shukui Qin, Jifeng Feng, Jianjin Huang, Yiping Zhang, Shun Lu, Manuela Zereu, Bernardo Garicochea, Cyntia Albuquerque Zadra, Henrik Riska, Tuomo Alanko, Jacques Cadranel, Christos Chouaid, Gérard Zalcman, Denis Moro Sibilot, Maurice Perol, Jaafar Bennouna, Pierre Fournel, Radj Gervais, Maciej Rotarski, Bruno Coudert, Michael Thomas, Thomas Wehler, Martin Faehling, Ulrich Keilholz, Eckart Laack, Joachim von Pawel, Rudolf Huber, Nicolas Dickgreber, Rainer Wiewrodt, Zsuzsanna Mark, Sandor Tehenes, Janos Strausz, Veronika Sarosi, Kumar Prabhash, Minish Jain, Srinivasan Venkatesan, Lalit Sharma, Hemant Dadhich, Rajnish Vasant Nagarkar, Amir Onn, Maya Gottfried, Solomon Stemmer, Maria Rita Migliorino, Francesco Grossi, Paolo Bidoli, Alessandra Bearz, Cesare Gridelli, Carlo Milandri, Marco Platania, Giovanni Luca Ceresoli, Giorgio Cruciani, Francisco Gutierrez Delgado, José Luis Gonzalez Perez, Gabriela Alvarado Luna, Othon Padilla Baca, J.G.J.V. Aerts, J.A. Stigt, A.M.C. Dingemans, G.J.M. Herder, S.J.M. Gans, Jorge Fernando Salas Sánchez, Renzo Luzgardo Alvarez Barreda, Wilbert Rodriguez Pantigoso, Osbert Luis Mejia Palomino, Piotr Jaskiewicz, Andrzej Kazarnowicz, Piotr Serwatowski, Aleksandra Szczesna, Jacek Jassem, Vladimir Lubennikov, Nina Karaseva, Sergey Orlov, Yuri Ragulin, Pilar Garrido, José Luis González Larriba, Carlos Camps, Rosario García Campelo, Pilar Lianes, Manuel Cobo, Enriqueta Felip, Dong-Wan Kim, Sang-We Kim, Joo-Hang Kim, Ji-Youn Han, Young-Chul Kim, Chih-Hsin Yang, Te-Chun Hsia, Yuh-Min Chen, Ying-Huang Tsai, Gee-Chen Chang, Thomas Chang-Yao Tsao, Wu-Chou Su, Ming-Shyan Huang, Ching-Liang Ho, Ruey-Kuen Hsieh, Yuriy Vinnyk, Oleksandr Popovych, Olga Ponomarova, Igor Bondarenko, Iryna Polishchuk, Riyaz Shah, Sanka Mitra, Sanjaykumar Popat, James Spicer, Elizabeth Toy, Toby Talbot, Emma Brown, Sunil Upadhyay, Yvonne Summers, Jayne Gurtler, Luis Meza, John Thropay
Background: Afatinib has demonstrated clinical benefit in patients with non-small-cell lung cancer progressing after treatment with erlotinib/gefitinib. This phase III trial prospectively assessed whether continued irreversible ErbB-family blockade w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf515edf6f94f014c68f3cf563cb2ea0
http://hdl.handle.net/11383/2118727
http://hdl.handle.net/11383/2118727
Autor:
David Cantú, Daniel R. Green, Gabriela Alvarado-Luna, Daniela Morales-Espinosa, Ernesto Soto Reyes Solis, Clementina Castro Hernandez, Fernanda Cisneros-Soberanis, Jerónimo Rodríguez-Cid, Iliana Alcala-Moreno, Daniel Motola, Luis A. Herrera
Publikováno v:
Journal of Clinical Oncology. 31:e22151-e22151
e22151 Background: Genetic and epigenetic alterations may promote the initiation or development of cancer. Global DNA hypomethylation and local hypermethylation have been observed, particularly in cell cycle control-associated genes, such as tumor su
Autor:
Daniela Morales-Espinosa, Ruben Cortes-Gonzalez, Daniel Motola, Lilian Monica Navarro-Garcia, Gabriela Alvarado-Luna, Daniel R. Green
Publikováno v:
Journal of Clinical Oncology. 30:e11098-e11098
e11098 Background: Breast cancer is the most common cancer in women in Mexico. It is mostly diagnosed at advanced stages. Objective: To describe the experience of image-guided biopsies of non-palpable breast tumors in a University Hospital in Mexico
Autor:
Daniel R. Green, Karla Sánchez-Lara, D. Motola-Kuba, Jerónimo Rodríguez-Cid, Gabriela Alvarado-Luna
Publikováno v:
Journal of Clinical Oncology. 29:e21068-e21068
e21068 Background: Metabolic syndrome is a worldwide public health problem. In Mexico, diseases related to metabolic syndrome are the cause of 81,900 deaths annually being the leading cause of mort...